Nephrotic syndrome after treatment of Crohn′s disease with mesalamine: Case report and literature review
Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recently, case reports have been published documenting the development of nephrotic syndrome after the treatment for inflammatory bowel disease with 5-aminosalicylic acid derivatives. We report a 50-year-old...
Guardado en:
Autores principales: | Belal M Firwana, Rim Hasan, Walid Chalhoub, Mazen Ferwana, Jin-Yong Kang, Joshua Aron, Joseph Lieber |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6a8c55573a024d3695735d2d905dc4ed |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Bioavailability and swallowability of an age-appropriate, delayed-release mesalamine formulation in healthy volunteers
por: Jakate A, et al.
Publicado: (2019) -
Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management
por: Igor G. Bakulin, et al.
Publicado: (2021) -
Experiencia local con natalizumab en pacientes con enfermedad de Crohn refractaria a anti-TNF: Casos clínicos
por: Fluxá,Daniela, et al.
Publicado: (2017) -
Estrés oxidativo, prooxidantes y enfermedad de Crohn
por: Tapia S,Alexis, et al.
Publicado: (2006) - Journal of Crohn's and colitis